Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
other information
Study period:
1996
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1996
Reference Type:
other: Draft Renewal Assessment Report under Regulation (EC) 1107/2009
Title:
Draft Renewal Assessment Report under Regulation (EC) 1107/2009 - Tritosulfuron
Year:
2018
Bibliographic source:
Draft Renewal Assessment Report under Regulation (EC) 1107/2009

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
other: B.13/B. 14
Qualifier:
according to guideline
Guideline:
other: EEC 92/69
Qualifier:
according to guideline
Guideline:
OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
not specified
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-amine
EC Number:
610-962-9
Cas Number:
5311-05-7
Molecular formula:
C5H5F3N4O
IUPAC Name:
4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-amine

Results and discussion

Any other information on results incl. tables

According to the currently valid OECD TG 471 (1997), approximately half log (i.e. √10 ≈ 3.2) intervals should be used for the dose level selection.


However, since the adequate spacing was not specified by the previous version of OECD TG 471 (1983), some dose groups are spaced by the factor of 5.


Nevertheless, since the mutant frequencies were not increased in any dose group up to the limit dose of 5000 μg/plate, this deviation is considered to be of minor importance and did not compromise the outcome of this study.


Therefore, this study is considered to have a deviation, but be acceptable.proximately half log (i.e. √10 ≈ 3.2) intervals should be used for the dose level selection.

Applicant's summary and conclusion

Executive summary:

According to the currently valid OECD TG 471 (1997), approximately half log (i.e. √10 ≈ 3.2) intervals should be used for the dose level selection.


However, since the adequate spacing was not specified by the previous version of OECD TG 471 (1983), some dose groups are spaced by the factor of 5.


Nevertheless, since the mutant frequencies were not increased in any dose group up to the limit dose of 5000 μg/plate, this deviation is considered to be of minor importance and did not compromise the outcome of this study.


Therefore, this study is considered to have a deviation, but be acceptable.proximately half log (i.e. √10 ≈ 3.2) intervals should be used for the dose level selection.